Used in pharmaceutical research as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH), this compound plays a role in modulating biological pathways related to inflammation, pain, and cardiovascular function. It has shown potential in preclinical studies for treating conditions such as neuropathic pain, hypertension, and inflammatory diseases due to its ability to stabilize endogenous epoxy fatty acids, which have protective effects in various tissues. Its spirocyclic structure and sulfonamide group enhance metabolic stability and target binding, making it a valuable scaffold in drug development. Commonly employed in in vivo and in vitro assays to explore sEH-related pathophysiology, it supports the discovery of new therapeutic agents targeting metabolic and inflammatory disorders.